Drug Shortage Report for APO-DICLOFENAC OPHTHALMIC
Report ID | 105296 |
Drug Identification Number | 02441020 |
Brand name | APO-DICLOFENAC OPHTHALMIC |
Common or Proper name | DICLOFENAC SODIUM |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | DICLOFENAC SODIUM |
Strength(s) | 0.1% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 5 ML |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-03 |
Estimated end date | 2023-03-03 |
Actual end date | 2023-03-01 |
Shortage status | Resolved |
Updated date | 2023-03-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-02-05 | English | Compare |
v2 | 2020-02-05 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v4 | 2023-02-09 | French | Compare |
v5 | 2023-03-03 | English | Compare |
v6 | 2023-03-03 | French | Compare |
Showing 1 to 6 of 6